Developing and Testing Health Warning Labels on the ENDS Device
RecruitingHealthy volunteers welcome
Who can join
Ages 21 to 35 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Generally healthy individuals (determined by physical examination). * Age of 21-35 years. * Is willing to provide informed consent. * Is willing to attend the lab as required by the study protocol. * ENDS users (defined as using ENDS either daily or occasionally in the past 30 days) * Have abstained from ENDS use for 12 hours prior to each session. Exclusion Criteria: * Report smoking cigarettes regularly (\> 5 cigarettes/month in the past year). * Report regular use of any other tobacco/nicotine product (e.g., e-cig, pipes, cigars) in the past year. * Women who are breast-feeding or test positive for pregnancy (by urinalysis at screening). * Individuals with self-reported history of chronic disease or psychiatric conditions. * Individuals with history of or active cardiovascular disease, low or high blood pressure, seizures, and regular use of prescription medications (other than vitamins or birth control). * Individuals that report the use of non-commercial (i.e., street) e-cigarette liquid or products * Individuals that report current EVALI or COVID-19 related symptoms (i.e., cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhea, fever, chills, or weight loss) * Individuals that have or have been exposed to COVID-19 in the last 14 days.
About the study
In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.
What is being tested
- Preferred ENDS (other)
- Preferred ENDS with HWL (other)
Sponsor: Florida International University · Participants: 80 · Started: Dec 13, 2023
Contact the study team
- Wasim Maziak, MD, PhD · Phone: 305-348-4501
Official record on ClinicalTrials.gov — NCT04907136
Locations in the U.S.
| Florida | Florida International University, Miami |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.